{
    "2020-03-11": [
        [
            {
                "time": "",
                "original_text": "64.66元/股！智飞生物二股东吴冠江大宗交易套现近20亿元 减持股份",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "吴冠江",
                        "大宗交易",
                        "套现",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "3月11日",
                "original_text": "A股共发生93宗大宗交易 成交38.46亿元（3月11日）",
                "features": {
                    "keywords": [
                        "A股",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)：持股5%以上股东吴冠江通过大宗交易方式转让3070万股",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "吴冠江",
                        "大宗交易",
                        "转让"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：股东吴冠江转让公司1.92%公司股份 减持股份",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "吴冠江",
                        "转让",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物现4笔大宗交易 共成交198,506.20万元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "潜江取消26号通告 新冠病毒起源于哪里？我国疫苗产业现状如何？",
                "features": {
                    "keywords": [
                        "潜江",
                        "新冠",
                        "病毒起源",
                        "疫苗产业"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "百家医药生物企业披露业绩快报，7家营收过百亿",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩快报",
                        "营收过百亿"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}